Skip to content

13F-HR filed by STATE OF WISCONSIN INVESTMENT BOARD

STATE OF WISCONSIN INVESTMENT BOARD filed this 13F-HR for the quarter ended 2019-03-31, filed 2019-05-13, with 1,537 holding rows worth $35,178,783,000.

Accession
0001097241-19-000005
Filed
2019-05-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2019

A holdings report, 1,537 entries on the cover page, a total value of $35,178,783,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $35,178,796,000 with VALUE read as thousands by filing date, 13F file number 028-02519. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Allena Pharmaceuticals, Inc.018119107COM15,600$110,000thousands by filing date
TTOO89853L104Stock41,500$109,000thousands by filing date
COHBAR INC COM NEW19249J109Stock31,400$102,000thousands by filing date
MENLO THERAPEUTICS INC586858102COM12,800$100,000thousands by filing date
ADMA BIOLOGICS INC000899104COM26,000$99,000thousands by filing date
SYNDAX PHARMACEUTICALS INC87164F105COM18,800$99,000thousands by filing date
NEOS THERAPEUTICS INC64052L106COM37,900$99,000thousands by filing date
MIRAGEN THERAPEUTICS INC60463E103COM35,400$99,000thousands by filing date
TETRAPHASE PHARMACEUTICALS INC88165N105COMMON STOCK71,000$95,000thousands by filing date
EXTRACTION OIL AND GAS INC30227M105COM21,634$92,000thousands by filing date
TURQUOISE HILL RESOURCES LTD900435108COMMON STOCK-FO54,995$91,000thousands by filing date
Mersana Therapeutics Inc59045L106Common Stock17,000$89,000thousands by filing date
NYMOX PHARMACEUTICAL CORP ORD SHS CorpP73398102Common Stock44,600$88,000thousands by filing date
FORTRESS BIOTECH INC34960Q109COM47,400$84,000thousands by filing date
CENTRAL EUROPEAN MEDIA ENTERPRISES LTD-CL AG20045202COM20,856$83,000thousands by filing date
SURFACE ONCOLOGY INC86877M209COM17,000$81,000thousands by filing date
FENNEC PHARMACEUTICALS INC31447P100COMMON STOCK15,600$76,000thousands by filing date
CORVUS PHARMACEUTICALS INC221015100COM18,500$74,000thousands by filing date
NEWLINK GENETICS CORP651511107COM38,300$74,000thousands by filing date
Ampio Pharmaceuticals03209T109COM131,100$74,000thousands by filing date
MUSTANG BIO INC62818Q104COM21,600$74,000thousands by filing date
MOLECULAR TEMPLATES INC608550109COM12,300$71,000thousands by filing date
APTINYX INC03836N103COM17,400$70,000thousands by filing date
RESTORBIO INC76133L103COM10,300$70,000thousands by filing date
CTI BIOPHARMA CORP12648L601COM68,400$66,000thousands by filing date
IDERA PHARMACEUTICALS INC45168K405COM PAR25,874$66,000thousands by filing date
TELIGENT INC NEW87960W104COM54,800$64,000thousands by filing date
PROTEOSTASIS THERAPEUTICS IN74373B109COM49,000$62,000thousands by filing date
NANTKWEST INC63016Q102COM37,700$60,000thousands by filing date
SELECTA BIOSCIENCES INC816212104COM24,200$57,000thousands by filing date
CLEARSIDE BIOMEDICAL INC185063104COM37,600$52,000thousands by filing date
INNOVATE BIOPHARMACEUTICLS I45782F105COM PAR24,800$48,000thousands by filing date
SIENNA BIOPHARMACEUTICALS IN82622H108COM20,900$48,000thousands by filing date
OVID THERAPEUTICS INC690469101COMMON STOCK17,600$31,000thousands by filing date
ACHAOGEN INC004449104COM42,100$19,000thousands by filing date
ZOMEDICA PHARMACEUTICALS COR98979F107COM55,200$19,000thousands by filing date
VITAL THERAPIES INC92847R104COM41,100$8,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001097241-19-000005this filing2019-05-13acceptance time not in the bulk data set